CareDx director granted 9,795 RSUs in stock award

Bickerstaff George reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bickerstaff George reported acquisition or exercise transactions in this Form 4 filing.

CareDx, Inc. director George Bickerstaff received an equity award in the form of 9,795 shares of Common Stock represented by restricted stock units. These RSUs were granted at no cash cost to him and are part of his compensation.

The RSUs vest 100% on the earlier of the one-year anniversary of the grant date or the day immediately before the first Annual Meeting that occurs after the grant date, subject to his continuous service through that time. Following this award, he holds 154,061 shares of Common Stock directly.

Insider Trade Summary 10b5-1

Grant/Award: 9,795 shares

Grant/Award 1 txn

Insider Bickerstaff George

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,795	$0.00	$0.00

Holdings After Transaction: Common Stock — 154,061 shares (Direct)

Footnotes (1)

1. F1. The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.

Key Figures

RSU grant size: 9,795 shares Grant price: $0.00 per share Post-transaction holdings: 154,061 shares +1 more

4 metrics

RSU grant size 9,795 shares Restricted stock units representing Common Stock granted to director

Grant price $0.00 per share Compensation-related RSU award with no cash paid by director

Post-transaction holdings 154,061 shares Total Common Stock held directly after the RSU grant

Vesting condition 100% cliff vesting Earlier of one year after grant or day before first Annual Meeting

Key Terms

restricted stock units ("RSUs"), Annual Meeting, continuous service

3 terms

restricted stock units ("RSUs") financial

"The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100%..."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Annual Meeting financial

"on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting..."

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

continuous service financial

"subject to the Reporting Person's continuous service on each applicable vesting date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CareDx (CDNA) report for George Bickerstaff?

CareDx reported that director George Bickerstaff received 9,795 shares of Common Stock represented by restricted stock units. These units were granted at no cash cost and are a compensation-related equity award, increasing his directly held position to 154,061 shares after the grant.

How many CareDx (CDNA) shares does George Bickerstaff hold after this award?

After the restricted stock unit award, George Bickerstaff holds 154,061 shares of CareDx Common Stock directly. This figure reflects his position immediately following the 9,795-share RSU grant reported, showing his total direct equity stake as of the transaction date.

What are the vesting terms of George Bickerstaff’s CareDx RSUs?

The reported CareDx restricted stock units vest 100% on the earlier of the one-year anniversary of the grant date or the day immediately before the first Annual Meeting after the grant date. Vesting is conditioned on Bickerstaff’s continuous service through the applicable vesting date.

Did George Bickerstaff buy CareDx (CDNA) shares in the open market?

No, the transaction reflects a grant of 9,795 restricted stock units representing Common Stock at a price of $0.00 per share. It is a compensation grant rather than an open-market purchase, so no cash was paid for these awarded shares.

What type of security did George Bickerstaff receive from CareDx?

George Bickerstaff received restricted stock units representing shares of CareDx Common Stock. Each RSU converts into Common Stock upon vesting, subject to the vesting schedule and his continuous service, effectively functioning as deferred share-based compensation rather than immediate stock delivery.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 05:48 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bickerstaff George

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BLVD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		A		9,795(1)	A	$0	154,061	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)